Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Government Resource

Public Meeting on Improving Patient Safety by Enhancing the Container Labeling for Parenteral Infusion Drug Products.

Fed Reg. Nov. 28, 2006;71:68819.

Save
Print
January 31, 2007
Fed Reg. Nov. 28, 2006;71:68819.

The US Food and Drug Administration invited experts to comment on how labels for intravenous drugs could be designed to ensure the safe use of these medications through informed label redesign efforts.

Save
Print
Cite
Citation

Fed Reg. Nov. 28, 2006;71:68819.

Related Resources From the Same Author(s)
Related Resources